Italy and Norway are going to suspend the COVID-19 vaccination with the British-Swedish company AstraZeneca after receiving information about the formation of blood clots in vaccinated citizens in Denmark. It is reported by the Norwegian Institute of Health and the Italian Medicines Agency (Aifa).
“Due to the reported death in Denmark due to a blood clot following the introduction of the AstraZeneca vaccine, Norway has decided to suspend vaccination with the drug,” the Health Institute said.
At the moment, the European Medicines Agency has begun research on this drug, but it is still impossible to understand whether there is a connection between the vaccine and blood clots, the Danish doctors noted.
Denmark previously suspended vaccination with AstraZeneca due to blood clots.